Plus Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersAutin, TX
SAM.gov UEINUN2VLR3MZD6
Plus Therapeutics develops targeted radiotherapeutics for cancer treatment. The company's portfolio includes REYOBIQ™ (rhenium Re186 obisbemeda), 188RNL-BAM, and CNSide®, designed to deliver radiation doses to tumors while minimizing damage to surrounding tissue. The company serves patients with recurrent glioblastoma, leptomeningeal metastases, pediatric brain cancer, hepatocellular carcinoma, and metastatic colorectal cancer, and also works in diagnostics.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Plus Therapeutics, INC. | Autin | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.